RXi Pharmaceuticals CEO to Present at the Future Leaders in the Biotech Industry Investment Conference

Posted: April 4, 2010 at 2:53 am

Story Summary: Hosted by BioCentury Publications and Thomson Reuters the Future Leaders in the Biotech Industry Investment Conference will be held at the Millennium Broadway Hotel & Conference Center in New York City. RXi has a comprehensive therapeutic platform that includes both novel RNAi compounds and advanced delivery methods that can be applied for local and systemic applications, against targets that may be undruggable by other modalities. RXi Pharmaceuticals believes it is well positioned to compete successfully in the RNAi-based therapeutics market with its accomplished scientific advisors, including Dr. Craig Mello, recipient of the 2006 Nobel Prize for his co-discovery of RNAi; a management team that is experienced in developing RNAi products; and a strong and early, but broad, intellectual property position in RNAi chemistry and delivery. Such statements include, but are not limited to, statements about future expectations, plan and future development of RXi Pharmaceutical Corporations products and technologies. Actual results may differ materially from those contemplated by these forward-looking statements. Actual results may differ materially from those contemplated by these forward-looking statements….Read the Full Story

Related posts:

  1. Inovio Biomedical to Present at Future Leaders in the Biotech Industry Conference
  2. RXi Pharmaceuticals Acquires Exclusive License to Proprietary, Potentially Paradigm-Changing RNAi Delivery Technology from Advirna LLC
  3. RXi Pharmaceuticals Appoints Noah D. Beerman as CEO


Related Post

Comments are closed.

Archives